Ebastine-d5
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Ebastine-d5
Description:
Ebastine-d5 is the deuterium labeled Ebastine. Ebastine (LAS-W 090) is an orally active, second-generation histamine H1 receptor antagonist. Ebastine can be used for the symptoms of allergic rhinitis and chronic idiopathic urticaria research[1][2].UNSPSC:
12352005Target:
Histamine Receptor; Isotope-Labeled CompoundsType:
Isotope-Labeled CompoundsRelated Pathways:
GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling; OthersApplications:
Metabolism-protein/nucleotide metabolismField of Research:
Inflammation/Immunology; EndocrinologySolubility:
10 mM in DMSOSmiles:
C (OC1CCN (CCCC (=O) C2=CC=C (C (C) (C) C) C=C2) CC1) (C3=C (C (=C (C (=C3[2H]) [2H]) [2H]) [2H]) [2H]) C4=CC=CC=C4Molecular Formula:
C32H34D5NO2Molecular Weight:
474.69References & Citations:
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.|[2]J Sastre. Ebastine in allergic rhinitis and chronic idiopathic urticarial. Allergy. 2008 Dec;63 Suppl 89:1-20.|[3]Fu-Ming Tsai, et al. Extracellular Signal-Regulated Kinase Mediates Ebastine-Induced Human Follicle Dermal Papilla Cell Proliferation. Biomed Res Int. 2019 Feb 11;2019:6360503.|[4]Fujii, et al. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats. Arzneimittelforschung. 1994 Apr;44 (4) :527-38.Shipping Conditions:
Room temperatureScientific Category:
Isotope-Labeled CompoundsClinical Information:
No Development ReportedIsoform:
H1 ReceptorCAS Number:
1216953-13-7
